Literature DB >> 11444377

The role of surfactant-associated protein A in pulmonary host defense.

V L Shepherd1, J P Lopez.   

Abstract

Resident alveolar macrophages play a key role in the initial defense against inhaled pathogens. Surface molecules bind opsonized as well as nonopsonized microbes and mediate their internalization by the macrophage. The recent discovery that specific C-type lectins can bind to the surface of a wide range of pathogens has led to the hypothesis that these lectins are involved in the initial phases of microbe recognition by the macrophage. Studies in our laboratory focus on the role of the lung-specific lectin surfactant associated protein A (SP-A) in host defense against pulmonary pathogens. SP-A contains a carbohdyrate recognition domain that appears to bind specifically to exposed carbohydrate residues on the surface of microorganisms. This lectin-microorganism interaction leads to entry of specific pathogens into macrophages and activation of intracellular pathways, resulting in the production of antimicrobial mediators such as nitric oxide. Many studies, including those involving SP-A-deficient mice, underscore the importance of this protein in pulmonary innate immunity. However, the intramacrophage mechanisms underlying the effects of SP-A are still unclear. This article describes our current knowledge of SP-A and its interactions with immune cells and pathogens with a focus on recent findings from our laboratory regarding SP-A interactions with mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444377     DOI: 10.1385/IR:23:2-3:111

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  47 in total

1.  Phagocytosis of viable Candida albicans by alveolar macrophages: lack of opsonin function of surfactant protein A.

Authors:  S Rosseau; A Guenther; W Seeger; J Lohmeyer
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

2.  Surfactant protein A protects growing cells and reduces TNF-alpha activity from LPS-stimulated macrophages.

Authors:  J C McIntosh; S Mervin-Blake; E Conner; J R Wright
Journal:  Am J Physiol       Date:  1996-08

3.  Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis.

Authors:  A M Walenkamp; A F Verheul; J Scharringa; I M Hoepelman
Journal:  Eur J Clin Invest       Date:  1999-01       Impact factor: 4.686

4.  Surfactant protein-A enhances respiratory syncytial virus clearance in vivo.

Authors:  A M LeVine; J Gwozdz; J Stark; M Bruno; J Whitsett; T Korfhagen
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  Surfactant protein A enhances mycobacterial killing by rat macrophages through a nitric oxide-dependent pathway.

Authors:  L F Weikert; J P Lopez; R Abdolrasulnia; Z C Chroneos; V L Shepherd
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-08       Impact factor: 5.464

6.  Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages.

Authors:  M D Williams; J R Wright; K L March; W J Martin
Journal:  Am J Respir Cell Mol Biol       Date:  1996-03       Impact factor: 6.914

7.  Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages.

Authors:  M J Tino; J R Wright
Journal:  Am J Physiol       Date:  1999-01

8.  Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages.

Authors:  L Maródi; H M Korchak; R B Johnston
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

9.  Differential regulation of the mannose and SP-A receptors on macrophages.

Authors:  Z Chroneos; V L Shepherd
Journal:  Am J Physiol       Date:  1995-12

10.  Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages.

Authors:  D Ohmer-Schröck; C Schlatterer; H Plattner; J Schlepper-Schäfer
Journal:  J Cell Sci       Date:  1995-12       Impact factor: 5.285

View more
  2 in total

1.  Mitogen-activated protein kinases and NFkappaB are involved in SP-A-enhanced responses of macrophages to mycobacteria.

Authors:  Joseph P Lopez; David J Vigerust; Virginia L Shepherd
Journal:  Respir Res       Date:  2009-07-01

Review 2.  Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome.

Authors:  Gavin D Perkins; Daniel F McAuley; Alex Richter; David R Thickett; Fang Gao
Journal:  Crit Care       Date:  2003-12-23       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.